These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer. Liang G, Zhu Y, Ali DJ, Tian T, Xu H, Si K, Sun B, Chen B, Xiao Z. J Nanobiotechnology; 2020 Jan 09; 18(1):10. PubMed ID: 31918721 [Abstract] [Full Text] [Related]
10. Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. Jang SC, Kim OY, Yoon CM, Choi DS, Roh TY, Park J, Nilsson J, Lötvall J, Kim YK, Gho YS. ACS Nano; 2013 Sep 24; 7(9):7698-710. PubMed ID: 24004438 [Abstract] [Full Text] [Related]
20. Strengthening Gastric Cancer Therapy by Trastuzumab-Conjugated Nanoparticles with Simultaneous Encapsulation of Anti-MiR-21 and 5-Fluorouridine. Hu N, Yin JF, Ji Z, Hong Y, Wu P, Bian B, Song Z, Li R, Liu Q, Wu F. Cell Physiol Biochem; 2017 Sep 24; 44(6):2158-2173. PubMed ID: 29241186 [Abstract] [Full Text] [Related] Page: [Next] [New Search]